Dimainvest S.r.l. has launched a voluntary public tender offer for Shedir Pharma Group S.p.A.
Dimainvest S.r.l. has initiated a voluntary public tender offer for the shares of Shedir Pharma Group S.p.A.
Dimainvest is a holding company owned by Umberto Di Maio, the controlling shareholder of Shedir Pharma Group.
Shedir Pharma Group manufactures and distributes nutraceuticals, cosmetics and medical devices. The company is headquartered in Piano di Sorrento, Italy.
Oaklins Italy’s parent company, Banca Akros, acted as the appointed broker for the collection of shares in the voluntary public tender offer for 11.9% of Shedir Pharma Group’s shares by Dimainvest.
Sprechen Sie mit dem Deal Team
Transaktionen
Cerbios-Pharma wurde von HAS Healthcare Advanced Synthesis übernommen.
Cerbios-Pharma S.A. wurde von HAS Healthcare Advanced Synthesis S.A. übernommen. Gemeinsam bilden sie eine weltweit führende CDMO-Gruppe mit komplementären Stärken in Entwicklung, Produktion und regulatorischer Unterstützung chemischer und biologischer Wirkstoffe. Die neue Gruppe vereint technologische Exzellenz mit umfassendem Know-how für die Anforderungen des globalen Pharmamarkts.
Mehr erfahreniwell raises US$31 million to deploy its leading European smart battery storage solutions into new markets
iwell, a developer of smart energy management (EMS) and battery storage systems (BESS), has successfully closed a US$31 million (€27 million) funding round. The round was led by Meridiam, with Invest-NL and Rabobank participating, alongside existing investors.
Mehr erfahrenGewiss S.p.A. has completed a mandatory public tender offer for Beghelli S.p.A.
Gewiss S.p.A. has successfully finalized a mandatory public tender offer for Beghelli S.p.A.
Mehr erfahren